Home

English
Afrikaans

CONTACT US
+27 21 888 3000
info@remgro.com

MENUMENU

About
Remgro
Investor
Centre
- - - Mediclinic Results
    - Events
Group
Investments
ESG and
sustainability
Media
Centre
- - - Media releases
    - Circulars
  - - Media contact
    - Logo Library

Remgro_Audit_and_Risk_Committee_Terms_of_Reference_Approved_by_Remgro_Board_on_23.03.2022

Posted 11:24 am by remgrowp_GKfsl9 & filed under .

LATEST NEWS

- - Report on proceedings at the AGM
    - SENS announcement
    - Approved targets – Remuneration Policy 2024

Audited summary consolidated results for the year ended 30 June 2024 and cash dividend declaration

SENS RELEASES

LATEST NEWS

- - Report on proceedings at the AGM
    - SENS announcement
    - Approved targets – Remuneration Policy 2024

Audited summary consolidated results for the year ended 30 June 2024 and cash dividend declaration

TCFD Report
2024

ESG and Sustainability
Report 2024

Annual Financial
Statements 2024

Integrated Annual
Report 2024

Overview

Head Office
Millennia Park
16 Stellentia Avenue
Stellenbosch, 7600

+27 21 888 3000
info@remgro.com

CAREERS
GROUP SITES

ETHICS HOTLINE 0800 222 536

Invenfin is the venture and growth capital division of Remgro

VISIT THE SITE >

2025 © Remgro Limited

E-mail Disclaimer | Terms of Use | Privacy Policy | PAIA | Site Map

About
Remgro
▼
Investor
Centre
▼
Group
Investments
▼
ESG and
sustainability
▼
Media
Centre
▼